arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Vyome Holdings, Inc

HIND
$2.05 ▲ +0.14 (+7.33%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
46 Visible periods
31 Metrics
Absolute Benchmarks
Price Chart
18
Health
Poor
Bearish Absolute basis
auto_awesome

Analytical Summary

On an absolute basis, Vyome Holdings, Inc shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $14.4M
Dividend Yield —
Revenue Growth -97.8% →
Op. Margin None
ROIC None
FCF / Share $-0.13 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

46-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$26.95K
↓ -97.8% —
Net Income Profit after all expenses
$-685.56K
↑ +73.9% —
Operating Margin Operating profit as % of sales
-222.4%
↓ -12.2% —
FCF / Share Free cash flow per share
$-0.13
↑ +40.0% —
Long-Term Debt Long-term obligations
$3.00M
↑ +2.2% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • FCF / Net IncomeFCF / Net Income of 0.37x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↑
18

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 13 years · 46 quarters